Clinical Trial Update: Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD) [Phase 1]

View source ↗

Summary

This is a Phase 1 dose-escalation trial of BAY85-3934 in adults with chronic kidney disease to assess safety, tolerability, pharmacodynamics, and pharmacokineti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• BAY85-3934

Snippet

Sponsor: Bayer | Conditions: Kidney Diseases | Phase 1 | Status: COMPLETED